mirapharmaceuticals.com (MIRA) - Gunggung dhuwit awis saben saham

MIRA Pharmaceuticals, Inc. - logo grafis emiten MIRA

MIRA Pharmaceuticals maintains a high reputation for developing safe, non-addictive analgesics, although the business relies on high-risk development amid fierce competition with industry behemoths. Innovations are focused on the synthesis of ketamine and THC analogs to combat depression. Monitoring of cash per share confirms financial stability, where 0.17 serves as the final level marker.

mirapharmaceuticals.com (MIRA): Dana dhuwit saben saham saka 21.02.2024 nganti 20.11.2026

Rincian metrik komprehensif lan analitis MIRA Pharma (MIRA)

- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:MIRA MIRA Pharmaceuticals, Inc.
Produk mawa merek MIRA Pharmaceuticals Inc.

For MIRA Pharmaceuticals (MIRA), cash per share reflects financial stability in organizing secure drug logistics and adhering to strict medical regulations. This metric is calculated by dividing total liquid assets by the number of outstanding securities. It determines the actual cash reserve available to cover operating expenses or debts. The trend of this indicator reveals hidden capital outflows prior to the publication of reports. While a high level of liquidity minimizes risks, it may signal inefficient capital utilization.